Cytokinetics, Incorporated - Common Stock — Quarterly Balance Sheet (NASDAQ:CYTK) | MetaTrader

Open full chart

News

Cytokinetics, Incorporated (CYTK) Discusses Positive Phase III Results From ACACIA-HCM Trial of Aficamten in Nonobstructive HCM Transcript

Cytokinetics Scores A First-Ever In Its Rivalry Against Bristol Myers

Can Camzyos' Growth Offset Bristol Myers' Patent Pressures?

Cytokinetics Gains 20.5% YTD: Buy, Sell or Hold the Stock?

CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong

Cytokinetics (CYTK) Reports Q2 Loss, Beats Revenue Estimates

Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for

Cytokinetics (CYTK) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Are Medical Stocks Lagging Concentra Group Holdings Parent, Inc. (CON) This Year?

All You Need to Know About Cytokinetics (CYTK) Rating Upgrade to Buy

Wall Street Analysts Think Cytokinetics (CYTK) Could Surge 30.54%: Read This Before Placing a Bet

Apple Shines As It Nears Fresh High, Leads 18 Hot Picks Onto Best Stock Lists